Real-world data in the era of immune checkpoint inhibitors

被引：0
|
作者：
Narita, Yukiya [1 ]
机构：
[1] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.428
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY5-5
引用
收藏
页码：S250 / S250
页数：1
相关论文
共 50 条
  • [21] Real-world use of immune checkpoint inhibitors in advanced or recurrent endometrial cancer
    Huepenbecker, Sarah
    Meyer, Larissa A.
    Craft, Miranda
    Chan, John K.
    Craggs, Christopher
    Lambert, Peter
    Lin, Yvonne G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024,
  • [22] Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer
    Pasello, Giulia
    Pavan, Alberto
    Attili, Ilaria
    Bortolami, Alberto
    Bonanno, Laura
    Menis, Jessica
    Conte, PierFranco
    Guarneri, Valentina
    CANCER TREATMENT REVIEWS, 2020, 87
  • [23] Utilization of real-world data to assess the effectiveness of immune checkpoint inhibitors (ICIs) in elderly patients with metastatic melanoma
    Ernst, D. S.
    McConkey, H.
    Liu, L.
    Butler, M. O.
    Petrella, T.
    Baetz, T.
    Koneru, R.
    Song, X.
    Cheng, T.
    Smylie, M. G.
    Rajagopal, S.
    Mihalcioiu, C.
    Gwadry-Sridhar, F.
    ANNALS OF ONCOLOGY, 2019, 30 : 553 - 553
  • [24] Real-World Data of Different Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer in China
    Miao, Kang
    Zhang, Xiaotong
    Wang, Hanping
    Si, Xiaoyan
    Ni, Jun
    Zhong, Wei
    Zhao, Jing
    Xu, Yan
    Chen, Minjiang
    Pan, Ruili
    Wang, Mengzhao
    Zhang, Li
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] Real-world data analyses unveiled the immune-related adverse effects of immune checkpoint inhibitors across cancer types
    Wang, Feicheng
    Yang, Shihao
    Palmer, Nathan
    Fox, Kathe
    Kohane, Isaac S.
    Liao, Katherine P.
    Yu, Kun-Hsing
    Kou, S. C.
    NPJ PRECISION ONCOLOGY, 2021, 5 (01)
  • [26] Real-world data analyses unveiled the immune-related adverse effects of immune checkpoint inhibitors across cancer types
    Feicheng Wang
    Shihao Yang
    Nathan Palmer
    Kathe Fox
    Isaac S. Kohane
    Katherine P. Liao
    Kun-Hsing Yu
    S. C. Kou
    npj Precision Oncology, 5
  • [27] Real-world data of immune-related adverse events in lung cancer patients receiving immune-checkpoint inhibitors
    Hu, Xiao
    Rodday, Angie Mae
    Gurinovich, Anastasia
    Pan, Stacey
    Salei, Yana V.
    Lin, Jeffrey H.
    Byrne, Margaret M.
    Cao, Yu
    Pai, Lori
    Parsons, Susan K.
    IMMUNOTHERAPY, 2025,
  • [28] Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real-world retrospective analysis
    Zhou, Chengjing
    Jiang, Ting
    Li, Rongzhen
    Yuan, Yan
    Xie, Weihao
    Huang, Xiaoxue
    Wang, Qiaoxuan
    Chang, Hui
    Chen, Gong
    Li, Yuhong
    Zeng, Zhifan
    Xiao, Weiwei
    Gao, Yuanhong
    CANCER COMMUNICATIONS, 2021, 41 (09) : 921 - 924
  • [29] Autoimmune Hematological Toxicities of Immune Checkpoint Inhibitors: A Real-World Pharmacovigilance Database Analysis
    Keerty, Dinesh
    Haddad, Philip A.
    Ramadas, Poornima
    Master, Samip R.
    BLOOD, 2022, 140 : 13160 - 13161
  • [30] Efficacy and safety of immune checkpoint inhibitors in older HCC patients: A real-world study
    Cheng, J.
    Chen, B.
    Lu, Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S338 - S338
12345